GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
CytoMed Therapeutics Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$0.85−0.03 (-3.17%)
Close on Oct 19, 2026
Debt
Borrowings on the balance sheet, Dec 31, 2025
Total debt
409.50K SGD
40.85K SGD due within a year
Net debt
-1.69M SGD
After 2.10M SGD of cash
Implied interest rate
4.97%
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, SGD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in CytoMed Therapeutics's annual report. Trading prices and yields need FINRA TRACE data.